Routine share withholding; mechanical by default.
Traded Aug 12, 2026 · Filed Aug 14, 2026
Incyte's President, Global Head of R&D sold $1.3M of Incyte shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,296,792
Shares × reported transaction price
15 days after results of Jul 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $120.77 on Aug 12, 2026, 48% above its 52-week low and 7% below its high, after a 7% rise over the previous 30 trading days
52-week range $81.66 (Sep 25, 2025) to $129.93 (Jul 28, 2026), 81% of the way up, from 251 adjusted closes. 30 trading days earlier: $113.36 on Jun 30, 2026. Describes the past only, not a forecast
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.6% | -1.2% | +4.8% |
| 30 days | +1.0% | -2.4% | +3.4% |
Past results only. Not a forecast.
Routine share withholding; mechanical by default.
Officer sold ~$1.36M of Incyte
Automatic saleFrom a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.